Department of Public Health Sciences, Hollings Cancer Center, Medical University of South Carolina, Charleston, South Carolina, USA.
Early Detection, Prevention and Infections Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.
Clin Infect Dis. 2023 Aug 14;77(3):419-424. doi: 10.1093/cid/ciad205.
Men who have sex with men (MSM) without HIV are known to be at elevated relative risk for Human papillomavirus (HPV)-associated anal cancer in comparison to men who have sex with women (MSW), but are poorly characterized in terms of anal cancer incidence due to absence of reporting of sexual behavior/identity at a population-level.
By combining age-specific statistics from multiple data sources (anal cancer incidence among all males; anal cancer incidence among MSM and MSW with HIV; population size of men with HIV by sexual orientation), we developed a mathematical model to estimate anal cancer incidence, annual number of cases, and proportion by (a) sexual orientation (MSM versus MSW), (b) HIV status, and (c) age (<30, 30-44, 45-59, and ≥60 years).
Anal cancer incidence (per 100 000) among MSM without HIV was 1.4 (95% uncertainty interval [UI], 0.6 to 2.3), 17.6 (95% UI = 13.8-23.5), and 33.9 (95% UI = 28.3-42.3), at ages 30-44, 45-59 and ≥60 years, respectively. 19.1% of all male anal cancer occurred in MSM without HIV, increasing from 4% of anal cancer diagnosed at 30-44 years to 24% at ≥60 years; 54.3% occurred in MSW without HIV (increasing from 13% at age 30-44 to 67% at >60 years), and the remaining 26.6% in men (MSM and MSW combined) with HIV (decreasing from 83% at age 30-44 to 9% at >60 years).
These findings should inform anal cancer prevention recommendations in male risk groups, including, for the first time, for the important group of MSM without HIV.
与与女性发生性行为的男性(MSW)相比,没有 HIV 的男男性行为者(MSM)已知存在人乳头瘤病毒(HPV)相关肛门癌的相对风险增加,但由于人群水平缺乏性行为/身份报告,因此在肛门癌发病率方面描述不足。
通过结合多个数据源的年龄特异性统计数据(所有男性的肛门癌发病率;HIV 阳性的 MSM 和 MSW 的肛门癌发病率;按性取向划分的 HIV 阳性男性人口规模),我们开发了一个数学模型来估计肛门癌发病率、年病例数和比例,按(a)性取向(MSM 与 MSW),(b)HIV 状态,和(c)年龄(<30、30-44、45-59 和≥60 岁)进行分类。
无 HIV 的 MSM 的肛门癌发病率(每 100000 人)分别为 1.4(95%不确定区间[UI],0.6 至 2.3)、17.6(95% UI=13.8-23.5)和 33.9(95% UI=28.3-42.3),年龄分别为 30-44、45-59 和≥60 岁。无 HIV 的 MSM 占所有男性肛门癌的 19.1%,从 30-44 岁诊断的肛门癌的 4%增加到≥60 岁的 24%;54.3%发生在无 HIV 的 MSW 中(从 30-44 岁的 13%增加到>60 岁的 67%),其余 26.6%发生在 HIV 阳性的男性(MSM 和 MSW 合并)中(从 30-44 岁的 83%下降到>60 岁的 9%)。
这些发现应该为男性风险群体中的肛门癌预防建议提供信息,包括首次为无 HIV 的重要 MSM 群体提供信息。